Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy

Figure 2

VTTQ and GAP-M discriminating NASH/SS suspects in NAFLD. (a) The median VTTQ and histological fibrosis stages (continuous line, best hit; dotted line, 95% confidence). (b) ROC of VTTQ distinguishing stages 0–2. (c) Four groups in VTTQ+ (see Figure 1, Normal (yellow)), Young (white), NASH suspects (red closed), SS suspects (blue), and Unspecified (red open) (continuous line, 99% confidence; dotted line, best hit). (d) AUROCs for GAP-M to distinguish NASH suspects from SS suspects (grey continuous line) or to distinguish histologically proven NASH from SS (black dotted line).

(a)

(b)

(c)

(d)